Lupin's Nanomi Stake in MPPI Rises to 56.28%

Lupin's subsidiary Nanomi B.V. (Netherlands) saw its stake in Multicare Pharmaceuticals Philippines rise from 51% to 56.28% effective March 30, 2026.
MPPI bought back 2,813,811 equity shares from existing shareholders using retained earnings; Nanomi did not participate in the buyback.
MPPI reported FY25 turnover of PHP 2,096.6 million and net worth of PHP 1,265.5 million as of March 31, 2025.